Blog

Japan rights deal boosts stem cell therapy group – Financial Times


Financial Times

Japan rights deal boosts stem cell therapy group
Financial Times
The deal will add credibility to a company founded by Sir Martin Evans, winner of the 2007 Nobel Prize for medicine for stem cell research, and chaired by Lord Digby Jones, former UK trade minister. The company's Heartcel product involves the injection
Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel™Business Wire (press release)



all 2 news articles »

2016-05-10 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.